Skip to main content
SpringerLink
Log in

Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for symptomatic atherosclerotic stenosis (≥70) in M1 segment of middle cerebral artery in 67 patients in 3 years. According to the stent types, the patients were classed as BMS and SES groups. The demographic characteristics, conventional risk factors of ischemic stroke, degree of stenosis, periprocedural complications, stent types, and clinical and angiographic outcomes were analyzed. There were 39 patients in the BMS group and 28 patients in the SES group. The demographic characteristics, conventional risk factors, and periprocedural complications were similar but different in residual stenosis after stenting in both groups (5.9% ± 9.9% vs. 14.4% ± 14.6%; P = 0.01). For the overall cohort, the rate of stroke or death and restenosis was 10.9% (7/66) and 24.5% (14/57), respectively. The frequency of restenosis was higher in the SES group than in the BMS group (log-rank, P = 0.04; crude hazard ratio = 3.03; 95% confidence interval (CI), 1.01–9.15; P = 0.049; and adjusted hazard ratio = 3.61; 95% CI, 1.06–12.27; P = 0.04); however, there was no difference in clinical outcomes (log-rank, P = 0.51; crude hazard ratio = 1.66; 95% CI, 0.36–7.61; P = 0.51; and adjusted hazard ratio = 0.59; 95% CI, 0.04–7.89; P = 0.69). The corrected degree of restenosis was higher in the SES than the BMS group. The prevalence of restenosis was higher in the SES than the BMS group, but the perioperative complications and follow-up clinical outcomes had no significant difference.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wong KS, Huang YN, Gao S et al (1998) Intracranial stenosis in Chinese patients with acute stroke. Neurology 50:812–813

    CAS  PubMed  Google Scholar 

  2. Chimowitz MI, Lynn MJ, Howlett-Smith H et al (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316

    Article  CAS  PubMed  Google Scholar 

  3. Arenillas JF, Molina CA, Montaner J et al (2001) Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 32:2898–2904

    Article  CAS  PubMed  Google Scholar 

  4. Thijs VN, Albers GW (2000) Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55:490–497

    CAS  PubMed  Google Scholar 

  5. The EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313:1191–1200

    Article  Google Scholar 

  6. Komotar RJ, Starke RM, Otten ML et al (2009) The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg 110:896–904

    Article  PubMed  Google Scholar 

  7. Sundt TM Jr, Smith HC, Campbell JK et al (1980) Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 55:673–680

    PubMed  Google Scholar 

  8. Mori T, Fukuoka M, Kazita K et al (1998) Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 19:1525–1533

    CAS  PubMed  Google Scholar 

  9. McKenzie JD, Wallace RC, Dean BL et al (1996) Preliminary results of intracranial angioplasty for vascular stenosis caused by atherosclerosis and vasculitis. AJNR Am J Neuroradiol 17:263–268

    CAS  PubMed  Google Scholar 

  10. Lee JH, Kwon SU, Suh DC et al (2003) Percutaneous transluminal angioplasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis 15:90–97

    Article  PubMed  Google Scholar 

  11. Kim JT, Lee SH, Choi SM et al (2009) Long-term durability of percutaneous transluminal angioplasty in patients with symptomatic middle cerebral artery stenosis. J Clin Neurol 5:24–28

    Article  PubMed  Google Scholar 

  12. Lee TH, Kim DH, Lee BH et al (2005) Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 26:166–174

    PubMed  Google Scholar 

  13. Bose A, Hartmann M, Henkes H et al (2007) A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 38:1531–1537

    Article  CAS  PubMed  Google Scholar 

  14. Fiorella D, Levy EI, Turk AS et al (2007) US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38:881–887

    Article  PubMed  Google Scholar 

  15. Miao ZR, Feng L, Li S et al (2009) Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 64:79–84

    Article  PubMed  Google Scholar 

  16. Jiang WJ, Du B, Leung TW et al (2007) Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 243:188–197

    Article  PubMed  Google Scholar 

  17. Jiang WJ, Wang YJ, Du B et al (2004) Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 35:1375–1380

    Article  PubMed  Google Scholar 

  18. Jiang WJ, Xu XT, Jin M et al (2007) Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 28:830–834

    PubMed  Google Scholar 

  19. Groschel K, Schnaudigel S, Pilgram SM et al (2009) A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 40:e340–e347

    Article  PubMed  Google Scholar 

  20. Levy EI, Turk AS, Albuquerque FC et al (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61:644–650

    Article  PubMed  Google Scholar 

  21. Samuels OB, Joseph GJ, Lynn MJ et al (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21:643–646

    CAS  PubMed  Google Scholar 

  22. Zaidat OO, Klucznik R, Alexander MJ et al (2008) The NIH registry on use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 70:1518–1524

    Article  CAS  PubMed  Google Scholar 

  23. Turk AS, Levy EI, Albuquerque FC et al (2008) Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 29:23–27

    Article  CAS  PubMed  Google Scholar 

  24. Singh M, Gersh BJ, McClelland RL et al (2004) Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109:2727–2731

    Article  PubMed  Google Scholar 

  25. Presbitero P, Carcagni A (2003) Gender differences in the outcome of interventional cardiac procedures. Ital Heart J 4:522–527

    PubMed  Google Scholar 

  26. Sick P, Huttl T, Niebauer J et al (2003) Influence of residual stenosis after percutaneous coronary intervention with stent implantation on development of restenosis and stent thrombosis. Am J Cardiol 91:148–153

    Article  PubMed  Google Scholar 

  27. Albuquerque FC, Levy EI, Turk AS et al (2008) Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery 63:23–27

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest Statement

Drs. X. Yue, Q. Yin, G. Xu, R. Zhang, Z. Zhou, M. Ma, and X. Liu have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, 305# East Zhongshan Road, Nanjing, 210002, Jiangsu Province, China

    Xuanye Yue, Qin Yin, Wusheng Zhu, Gelin Xu, Renliang Zhang, Zhiming Zhou, Minmin Ma & Xinfeng Liu

  2. Department of Neurology, Shiyan People Hospital, Yunyang Medical College, Shiyan, Hubei Province, China

    Xuanye Yue & Gangming Xi

  3. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, China

    Guangfu Jin

Authors
  1. Xuanye Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qin Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gangming Xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wusheng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gelin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renliang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhiming Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Minmin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Guangfu Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xinfeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xinfeng Liu.

Additional information

Xuanye Yue and Qin Yin contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yue, X., Yin, Q., Xi, G. et al. Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis. Cardiovasc Intervent Radiol 34, 54–60 (2011). https://doi.org/10.1007/s00270-010-9885-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-010-9885-z

Keywords

Search

Navigation